Cover Image
市場調查報告書

Zambon Company S.p.A.:產品平台分析

Zambon Company S.p.A. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 293897
出版日期 內容資訊 英文 31 Pages
訂單完成後即時交付
價格
Back to Top
Zambon Company S.p.A.:產品平台分析 Zambon Company S.p.A. - Product Pipeline Review - 2015
出版日期: 2015年12月23日 內容資訊: 英文 31 Pages
簡介

Zambon Company S.p.A.是正在製造治療藥及精細化學品的製藥企業,分製藥,化學,以及產業振興3個部門發展產業。製藥產業主要網羅呼吸系統,疼痛管理,女性用健康管理用品等,化學藥品部門則提供客製化化合物和非專利原料藥,以及產業振興部門藥物輸送技術概念等。

本報告提供Zambon Company S.p.A.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,以及最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Zambon Company S.p.A.的基本資料

  • Zambon Company S.p.A.概要
  • 主要資訊
  • 企業資料

Zambon Company S.p.A.:R&D概要

  • 主要的治療範圍

Zambon Company S.p.A.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Zambon Company S.p.A.:開發中產品概況

  • 最後階段的開發中產品
    • 登記前的產品/聯合治療模式
  • 初期階段的開發中產品
    • 藥物研發中的產品/聯合治療模式

Zambon Company S.p.A.:開發階段不明的開發中產品

  • 開發階段不明的產品/聯合治療模式

Zambon Company S.p.A.:藥物簡介

  • safinamide
  • ZP-031
  • ZP-037
  • ZP-040
  • ZP-042
  • ZP-049
  • ZP-003
  • ZP-006
  • ZP-008
  • ZP-044

Zambon Company S.p.A.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Zambon Company S.p.A.:最近的開發平台趨勢

Zambon Company S.p.A.:暫停中的計劃

Zambon Company S.p.A.:企業發表

Zambon Company S.p.A.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07895CDB

Summary

Global Markets Direct's, 'Zambon Company S.p.A. - Product Pipeline Review - 2015', provides an overview of the Zambon Company S.p.A.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Zambon Company S.p.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Zambon Company S.p.A. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Zambon Company S.p.A.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Zambon Company S.p.A.'s pipeline products

Reasons to buy

  • Evaluate Zambon Company S.p.A.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Zambon Company S.p.A. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Zambon Company S.p.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Zambon Company S.p.A. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Zambon Company S.p.A.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Zambon Company S.p.A. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Zambon Company S.p.A. Snapshot
    • Zambon Company S.p.A. Overview
    • Key Information
    • Key Facts
  • Zambon Company S.p.A. - Research and Development Overview
    • Key Therapeutic Areas
  • Zambon Company S.p.A. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Zambon Company S.p.A. - Pipeline Products Glance
    • Zambon Company S.p.A. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
    • Zambon Company S.p.A. - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • Zambon Company S.p.A. - Drug Profiles
    • ZP-040
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ZP-046
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ZP-049
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ZP-053
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ZP-003
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ZP-008
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ZP-044
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ZP-051
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Zambon Company S.p.A. - Pipeline Analysis
  • Zambon Company S.p.A. - Pipeline Products by Route of Administration
  • Zambon Company S.p.A. - Pipeline Products by Molecule Type
  • Zambon Company S.p.A. - Dormant Projects
  • Zambon Company S.p.A. - Company Statement
  • Zambon Company S.p.A. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Zambon Company S.p.A., Key Information
  • Zambon Company S.p.A., Key Facts
  • Zambon Company S.p.A. - Pipeline by Indication, 2015
  • Zambon Company S.p.A. - Pipeline by Stage of Development, 2015
  • Zambon Company S.p.A. - Monotherapy Products in Pipeline, 2015
  • Zambon Company S.p.A. - Partnered Products in Pipeline, 2015
  • Zambon Company S.p.A. - Partnered Products/ Combination Treatment Modalities, 2015
  • Zambon Company S.p.A. - Preclinical, 2015
  • Zambon Company S.p.A. - Unknown, 2015
  • Zambon Company S.p.A. - Pipeline by Route of Administration, 2015
  • Zambon Company S.p.A. - Pipeline by Molecule Type, 2015
  • Zambon Company S.p.A. - Dormant Developmental Projects,2015
  • Zambon Company S.p.A., Other Locations
  • Zambon Company S.p.A., Subsidiaries

List of Figures

  • Zambon Company S.p.A. - Pipeline by Top 10 Indication, 2015
  • Zambon Company S.p.A. - Pipeline by Stage of Development, 2015
  • Zambon Company S.p.A. - Monotherapy Products in Pipeline, 2015
  • Zambon Company S.p.A. - Partnered Products in Pipeline, 2015
  • Zambon Company S.p.A. - Pipeline by Top 10 Molecule Type, 2015
Back to Top